Free At-Home COVID-19 Test Program Returns as Cases Rise
Drug Topics
AUGUST 27, 2024
The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.
Tue.Aug 27, 2024
212 
21 cases of little-known Oropouche virus detected in U.S.
STAT
AUGUST 27, 2024
Nearly two dozen people in the United States have been confirmed to have contracted the Oropouche virus during travels outside the country this summer, the Centers for Disease Control and Prevention reported Tuesday. A previously little-known virus, Oropouche has garnered headlines in recent weeks with reports of a small number of deaths and a possible link to congenital malformations in babies infected in the womb.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount
Fierce Pharma
AUGUST 27, 2024
Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.
STAT+: To help migraine patients — and sell more medicines — major drugmakers turn to telehealth
STAT
AUGUST 27, 2024
In 2021, Katey Frederking had reached the end of her rope. The 29-year-old was struggling with frequent migraines, which started after a concussion from a fall on an icy patch near her home in Chicago. The medications she had been prescribed weren’t working, her doctor wasn’t listening, and she was facing several months of wait time before she could see a new neurologist.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Feds killed plan to curb Medicare Advantage overbilling after industry opposition
Fierce Healthcare
AUGUST 27, 2024
A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars—only to abruptly back off amid an “uproar” fr | Filings and testimonies in a multibillion-dollar Justice Department civil fraud case against UnitedHealth Group outline industry pressure that led the government to bury a proposed rule on Medicare Advantage chart reviews.
STAT+: Lilly launches Zepbound vials in move that could ease supply constraints
STAT
AUGUST 27, 2024
Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug Zepbound through its direct-to-consumer platform, a move that will likely ease supply constraints and draw more patients to the company’s online portal. Lilly is also selling the vials at a discount to the currently available injectable pens, which carry a list price of $1,060 for a month’s supply.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: To stop mpox from becoming the next pandemic, we must address global vaccine inequities
STAT
AUGUST 27, 2024
In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as a painful rash spread over their body. We were in uncharted territory — there were no proven treatments, and the number of cases was rapidly increasing.
FTC Issues Support Statement for FDA’s Draft Guidance on Interchangeable Biosimilars
Pharmacy Times
AUGUST 27, 2024
The guidance, if finalized, would revise considerations about switching studies for proposed interchangeable biosimilars.
Opinion: The importance of reducing the financial burden of participating in clinical trials
STAT
AUGUST 27, 2024
Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and other diseases. Essential for the development of new therapies are the thousands of people who volunteer to participate in clinical trials every year, helping to characterize the safety and effectiveness of treatments and vaccines. They raise their hands not knowing if the trial will help, only knowing they will be part of a journey toward possible breakthroughs that will improve or
TennCare violated healthcare rights of Tennessee Medicaid beneficiaries, judge rules
Fierce Healthcare
AUGUST 27, 2024
TennCare, the state of Tennessee’s Medicaid program, intentionally prevented families from receiving healthcare coverage and benefits, a federal district judge determined Aug. 26. | TennCare, the Tennessee state Medicaid program, was found to have intentionally prevented families from receiving healthcare coverage and benefits, a federal court found.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Centene eliminates brokers’ commissions for Medicare drug plans
STAT
AUGUST 27, 2024
Health insurer Centene will not pay any commissions to brokers and agents who help people sign up for next year’s Medicare prescription drug plans. “We have made a difficult decision — effective Jan. 1, 2025 — to cease new and renewal commissions for [Medicare Part D plans] beginning with the 2025 plan year,” Centene’s WellCare subsidiary said last Friday in an email sent to brokers, which was obtained by STAT.
SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says
Fierce Pharma
AUGUST 27, 2024
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.
Lung Cancer and Treatment Options: A Guide for Pharmacists
Pharmacy Times
AUGUST 27, 2024
Pharmacists have been shown to contribute to improved adherence rates, therapy optimization, patient safety, and cost-savings.
Pfizer and Lilly want to sell you drugs directly
STAT
AUGUST 27, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, and thank you for sticking with us ahead of Labor Day weekend. I’ll be visiting Austin for the weekend and would welcome any recommendations!
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Updated Cardiovascular Guidelines for Individuals with HIV Expand Statin Eligibility
Pharmacy Times
AUGUST 27, 2024
Medication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.
Pfizer joins Lilly in direct-to-consumer drive
pharmaphorum
AUGUST 27, 2024
Pfizer has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access.This morning, the company announced the launch in the US of PfizerForAll, a digital platform that it says provides access to same-day appointments with healthcare professionals – in-person or via a $35 telehealth visit – along with home delivery of medicines and diagnostics, vaccination appointments, and payment support.
FDA Approves True Sight Oncology Comprehensive Test to Identify NTRK Solid Tumors
Pharmacy Times
AUGUST 27, 2024
With diagnostic tools, oncology pharmacists and other health care providers can help to identify treatments that have the best probability of working for a specific patient.
Roche gets EU nod for subcutaneous PNH drug PiaSky
pharmaphorum
AUGUST 27, 2024
Roche's PiaSky is the first therapy for rare blood disorder PNH that can be given by monthly subcutaneous injection in the EU.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
AstraZeneca investment to increase biologic capacity in Sweden
European Pharmaceutical Review
AUGUST 27, 2024
AstraZeneca has announced the largest single investment in its Sweden Biomanufacturing Center in Södertälje, since the facility opened in 2021. The additional $135 million investment will increase the biopharmaceutical facility area by 50 percent. An existing building within AstraZeneca in Södertälje is set to be expanded by 2,700m 2 , the company explained.
MBX joins IPO queue with $100m Nasdaq filing
pharmaphorum
AUGUST 27, 2024
US biotech MBX Biosciences, files for an IPO, seeking around $100 million to take a hypoparathyroidism candidate into phase 3
School Openings After COVID-19 Lockdowns Associated with Increased Psychiatric Emergencies
Drug Topics
AUGUST 27, 2024
Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.
J&J's Balversa is first pan-FGFR bladder cancer drug in EU
pharmaphorum
AUGUST 27, 2024
J&J's Balversa has been approved in the EU for advanced bladder cancer with FGFR3 genetic alterations after one line of prior therapy
Eli Lilly: Tirzepatide Single-Dose Vials Available for Cash-Pay Patients
Drug Topics
AUGUST 27, 2024
Vials of tirzepatide 2.5 mg and 5 mg will be available at a 50% discount compared with the list price of other incretin-based obesity medications.
After FDA no, Regeneron gets yes from EU on odronextamab
pharmaphorum
AUGUST 27, 2024
Regeneron's Ordspono (odronextamab) for non-Hodgin lymphoma (NHL) is cleared in EU five months after being turned down by the FDA
In Depth Perspectives: Importance of Patient Advocacy, PBM Scrutiny, and More
Drug Topics
AUGUST 27, 2024
Check out these top featured stories from Drug Topics in August 2024.
Singapore approves mpox vaccine as it adds border infection checks
Pharmaceutical Technology
AUGUST 27, 2024
Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case.
HDA 2024 Traceability Seminar: An FDA Perspective on DSCSA
Pharmaceutical Commerce
AUGUST 27, 2024
The agency provides an update surrounding the Act’s implementation efforts.
As pharma’s AI revolution gets underway, ‘hallucinations’ pose a great risk
PharmaVoice
AUGUST 27, 2024
While AI, machine learning and large language models can distill huge amounts of information, they sometimes make mistakes. New technologies could rebuild that trust.
Northwell, Nuvance merger wins state AGs' blessing
Fierce Healthcare
AUGUST 27, 2024
Northwell Health and Nuvance Health’s 28-hospital merger logged a key milestone Monday with word that Connecticut and New York’s attorneys general have conditionally signed off on the deal. | The attorneys general secured promises to maintain care services in western Connecticut and limit rate negotiations to single states. The $18 billion deal still awaits all-clears from state regulatory offices.
Can stress cause nosebleeds?
The Checkup by Singlecare
AUGUST 27, 2024
Picture this: You’re hiking in the Rocky Mountains, enjoying the sight of lush forests, alpine meadows, and sparkling lakes. Enraptured by the view, you don’t notice the blood trickling down your nose until it splatters on your shirt. You’re not surprised, though—dry conditions and high altitude create the perfect environment for a bloody nose. You pinch your nose to stop the bleeding and continue on your way.
Pharma Pulse 8/27/24: Inside a Love-Hate Relationship With ChatGPT, Virtual Care's Role in Behavioral Health & more
Pharmaceutical Commerce
AUGUST 27, 2024
The latest news for pharma industry insiders.
How to Manage Cholesterol in Your Pharmacy
PioneerRx
AUGUST 27, 2024
71 million Americans have high cholesterol, according to Johns Hopkins Medicine. Another 25 million have elevated cholesterol levels, which significantly.
Let's personalize your content